F.N.B. Corporation

Executive Summary

BUY, Medium conviction. Rated BUY, Medium conviction. The stock sits at $18.75, about 10.0% below its 52-week high, while the quant engine points to a $26.19 target, or 39.7% upside. The setup is attractive because the market is discounting the FY26 net interest income reset, but not giving enough credit for 17% y/y Q2 EPS growth, a better 53.7% efficiency ratio, lower provision guidance, and ongoing buybacks with over $250M still authorized.

Investment Thesis

FNB is being priced like a middling regional bank with little earnings momentum, but the current facts are better than that. The stock trades at 11.34x earnings, below the 13.7x peer average, and at just 0.99x book, yet the bank produced 22.1% net margin in FY2025 and just posted 17% y/y EPS growth in Q2 2026. That gap between valuation and underlying profitability is the core opportunity.

The market is focused on the FY26 NII cut, and that concern is valid. Management explicitly lowered full-year NII to $1.485B-$1.515B because of deposit competition and tighter loan spreads. But the market appears to be underweighting the offsets. Loan growth was still 7.5% annualized linked quarter, period-end loans and deposits are both still guided at mid-single-digit growth, provision guidance was reduced to $80M-$95M, and the efficiency ratio improved to 53.7%. This is not a bank seeing broad franchise erosion. It is a bank navigating a tougher funding environment while still growing and controlling expenses.

The case depends on three things. First, NII needs to trough rather than keep stepping down, with Q3's $375M-$385M guide the key marker. Second, management needs to be right that CRE payoff pressure dissipates in Q4, because that should help volume translate into revenue more cleanly. Third, capital return needs to stay active. The $47M repurchased in Q2 and over $250M still authorized matters at this valuation.

Conviction stays at Medium because the earnings path is not clean enough for a higher stance. FY2025 revenue was still down 6.8% YoY, and short interest at 8.89% shows skepticism remains elevated. But at $18.75, investors are not paying for much recovery. If FNB simply proves that spreads stabilize, credit remains sound, and expenses stay controlled, the stock does not need heroic assumptions to move materially higher toward the quant target.

Key Metrics

Financial Strength

The balance sheet read is solid enough for a BUY, even if not pristine enough for High conviction. Leverage looks manageable with debt/equity of 0.39 and debt/EBITDA of 3.59, while profitability remains strong with a 22.1% net margin and high quality sub-scores in profitability (93) and cash flow quality (89). The weak point is not solvency, it is earnings mix and cash generation, with only $0.1B of FCF in FY2025 and a bank-style 0.16 current ratio that is not very informative on its own. Margin direction has improved operationally through efficiency gains, but the bigger earnings variable remains spread pressure rather than cost control.

Competitive Position

FNB's edge is relationship banking in its regional footprint, funded by a sticky deposit base and broad commercial client touchpoints. That moat is not wide, but it is real, because local market knowledge, treasury services, and underwriting relationships are difficult for digital-only entrants to replicate at scale. Durability depends on maintaining funding discipline, since the current pressure point is not credit but deposit pricing and loan spreads.

Management & Guidance

Management's current guide is cautious but not broken. The headline change was the FY26 NII reduction to $1.485B-$1.515B, and CFO Vince Calabrese was explicit that this reflects both first-half results and ongoing deposit competition. At the same time, period-end loans and deposits are still expected to grow mid-single digits, Q3 NII is guided to $375M-$385M, non-interest income to $370M-$390M, and provision expense was cut to $80M-$95M. Given the recent earnings record, which includes strong beats in 5 of the last 8 quarters and only modest misses, management deserves partial credibility, but not a free pass, because spread assumptions have been the area of the most visible reset.

Segment Analysis

• Net interest income (FY26 guide $1.485B-$1.515B): Core earnings driver, pressured by deposit competition and tighter loan spreads in 2026
• Non-interest income (FY26 guide $370M-$390M): Provides diversification, with prior periods supported by capital markets and fee income
• Commercial lending (Not separately disclosed in provided data): C&I was a key growth driver in Q2, supporting 7.5% annualized linked-quarter loan growth
• Consumer lending (Not separately disclosed in provided data): Consumer also contributed to Q2 loan growth, partially offsetting CRE payoff headwinds
• Deposit franchise (Period-end deposits guided mid-single digits growth for FY26): Public funds are expected to add about $0.5B of seasonal inflow in 2H before normal reversal

Capital Allocation

Capital allocation looks sensible. Management repurchased $47M of stock in Q2 and still has over $250M available, which is attractive with the shares at 0.99x book and below peer earnings multiples. FCF was only $0.1B in FY2025, so flexibility is not unlimited, but the balance sheet is not stretched with debt/equity of 0.39 and the historical focus on CET1 and loan-to-deposit improvement suggests a disciplined posture.

Management Execution & Track Record

Execution has been better than perfect-looking headline numbers suggest. Since the 2024 Q3 call, management did deliver on the broad balance-sheet agenda: they had highlighted a record CET1 of 10.4%, improving funding, and 2025 cost initiatives, and the current quarter shows that with 53.7% efficiency, more than 100 bps better y/y, plus positive operating leverage and 17% y/y EPS growth to $0.42. They also said in 2024 that total deposits were expected to grow mid-single-digits, up from low-single-digits, and the current FY26 guide still calls for mid-single-digit deposit growth despite stronger competition. The miss is on spread outlook. In 2024 they were leaning on deposit repricing benefits after rate cuts and said, "What our guidance implies is like a 15% beta by the end of this year. You know, I'd like to think we can do better than that." Instead, 2026 has brought enough deposit competition that FY26 NII was cut to $1.485B-$1.515B. The beat-miss record still supports credibility, with 5 beats, 2 misses, and 1 in-line over the last eight reported quarters, including a 22.0% beat in January 2026.

Positioning & Flows

Ownership is institutionally heavy, with the top three holders at 66.9%, which usually dampens retail-driven volatility but can also limit surprise upside from new sponsorship. Short interest is elevated at 8.89%, or 31.1M shares, with 5.4 days-to-cover, so the setup can squeeze if NII and margins stabilize. Options positioning is reported as a positive GEX regime, which usually points to less chaotic near-term trading rather than a high-conviction directional signal.

Bull Case

• Q2 2026 showed real operating progress: management reported record revenue of $463M, 9% PPNR growth, and an efficiency ratio of 53.7%, improved by more than 100 bps y/y.
• Loan growth remains solid despite a competitive market, with loans up 7.5% annualized linked quarter, led by C&I and consumer, and management still guiding mid-single-digit period-end loan growth for FY26.
• Credit has been better than expected, which is why management lowered the FY26 provision outlook to $80M-$95M. That matters because it offsets part of the NII pressure and supports forward EPS durability.
• Capital return is active again: FNB repurchased $47M of stock in Q2 and still has over $250M of authorization remaining, meaningful for a $6.8B market cap company trading below peer multiples.

Bear Case

• The central negative is explicit: CFO Vince Calabrese said, "Full year net interest income guidance has been revised to a range of $1.485 billion-$1.515 billion due to a combination of our first half results and our expectation for a continuation of heightened deposit competition within the industry."
• Margin pressure has not broken yet. Q2 NIM was only 325 bps, flat q/q, and management said higher-quality commercial production is coming on at tighter spreads, which limits near-term upside even if volumes grow.
• FY2025 revenue declined 6.8% YoY to $2.7B, so the bank is not yet showing clean revenue acceleration on a full-year basis despite better recent quarter trends.
• Short interest is elevated at 8.89% of shares, or 31.1M shares with 5.4 days-to-cover, which signals a meaningful market cohort is still betting that earnings pressure persists.

Valuation & Price Target

Engine price target $26.19 (+39.7% vs current), Medium confidence.

• P/E Multiple: $23.34 (28% weight)
• P/S Multiple: $28.92 (20% weight)
• Quality-adjusted: $22.84 (20% weight)
• DCF: $93.5 (1% weight)

The rating aligns with the quant baseline BUY and the $26.19 engine target. The reason not to upgrade conviction above Medium is simple: the valuation case is obvious at 11.34x P/E versus 13.7x peers, but management just lowered FY26 NII guidance and Q2 NIM was only 325 bps, so the rerating still needs earnings proof. Sell-side consensus is positive, but that is low-signal context here. The real support for BUY is the combination of low valuation, 17% y/y Q2 EPS growth, lower provision guidance, and active repurchases against a stock still 10.0% below its high.

Risk Assessment

Risk score 38/100 (Low). The biggest risk is that deposit competition and tighter loan spreads keep NII stuck near the low end of the new $1.485B-$1.515B FY26 range, preventing the stock from closing its valuation gap versus peers.

The Bottom Line

FNB rates BUY at Medium conviction. The stock is cheap at 11.34x earnings and 0.99x book, the operating trend is better than the headline NII cut implies, and buybacks add support at this level. The market is giving too much weight to near-term spread pressure and too little to improving efficiency, lower credit costs, and normalized 2027 earnings power. The call would weaken if Q3 NII misses the $375M-$385M guide or if NIM remains stuck near 325 bps without a visible Q4 improvement.